Reining in Recurrent Clostridium difficile Infection—Who's at Risk?
No abstract is available. To read the body of this article, please view the Full Text online.
Conflicts of interest The author is on the speaker's bureau for Viropharma and Biocodex Inc.
PII: S0016-5085(09)00203-0
doi:10.1053/j.gastro.2009.02.023
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
-

Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
, 15 December 2008

